GWPH GW Pharmaceuticals Plc

119.53
-1.33  -1%
Previous Close 120.86
Open 119.57
Price To Book 9.08
Market Cap 3650799770
Shares 30,542,958
Volume 324,406
Short Ratio
Av. Daily Volume 540,697

SEC filingsSee all SEC filings

  1. 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] 181206900
  2. 8-K - Current report 181203158
  3. 8-K - Current report 181201029
  4. 8-K - Current report 181111245
  5. 424B5 - Prospectus [Rule 424(b)(5)] 181106125

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data released February 7, 2017.
Tetrahydrocannabinol (THC) and cannabidiol (CBD)
Glioblastoma Multiform- cancer
Phase 2 open-label trial to commence 1Q 2019.
GWP42006 (CBDV)
Rett syndrome
Phase 3 initiated December 2016. Part A nearing completion, unlikely to continue through to Part B.
Epidiolex
Infantile spasms (IS)
Phase 2 trial did not meet endpoint
GWP42004
Type 2 diabetes
Phase 3 trials failed. Evaluating whether there are any next steps
Sativex
Cancer pain
Phase 2 data released February 21, 2018 - primary endpoint not met.
GWP42006 (CBDV)
Epilepsy
Phase 2 data released September 2015. Currently evaluating next steps
GWP42003
Schizophrenia
Approval announced June 25, 2018.
Epidiolex
Dravet Syndrome and Lennox-Gastaut syndrome
Phase 3 data due 1H 2019.
Epidiolex
Tuberous Sclerosis Complex
Phase 3 trial planned for 2H 2018.
Sativex
Spasticity due multiple sclerosis
GWP42006 (CBDV)
Autism

Latest News

  1. Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
  2. GW Pharmaceuticals PLC (GWPH) Stock Moves -1.1%: What You Should Know
  3. 4 Marijuana Stocks To Watch On Thursday
  4. Why Marijuana Stock GW Pharmaceuticals Dropped 10.5% in November
  5. Cannabis Winners in 2018 Poised for a Bigger 2019
  6. Electricity Usage By Cannabis Growers Ballooning
  7. Marijuana Stocks Gain Attention As Cannabis Industry Jobs Grow
  8. 2 Must-Read Quotes on Marijuana From FDA Head Scott Gottlieb
  9. Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals
  10. What the Future Holds for Canopy Growth Stock
  11. These 17 Pot Stocks Were Throttled in November
  12. GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know
  13. Bank Of America Bullish On GW Pharma, Expects Growth In Epidiolex Sales
  14. Marijuana Stocks Get Boost On Deal News
  15. Cantor Fitzgerald Lowers GW Pharmaceuticals Price Target
  16. How dangerous are marijuana stocks? Even a company with notable achievements has plunged
  17. The Marijuana Stocks Making Waves This Week
  18. The 12 Largest Marijuana Stocks
  19. You'll Never Guess Which Asian Country Just Legalized Medical Marijuana
  20. Serious Questions Surround CV Sciences Stock

SEC Filings

  1. 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] 181206900
  2. 8-K - Current report 181203158
  3. 8-K - Current report 181201029
  4. 8-K - Current report 181111245
  5. 424B5 - Prospectus [Rule 424(b)(5)] 181106125
  6. 8-K - Current report 181097630
  7. 424B5 - Prospectus [Rule 424(b)(5)] 181097609
  8. 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] 181089930
  9. 8-A12B/A [Amend] - Registration of securities [Section 12(b)] 181082573
  10. 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] 181082185